Need immediate assistance? Call 1-518-730-0559 (Us-Canada Toll Free) or Contact Us

 

Global Market Study on Herpes Marker Testing: Antibody/Antigen Based Kits to be the Most Attractive Segment by Test Type During the Forecast Period 2017 – 2025

Table of Content

1. Executive Summary
   1.1. Market Overview
   1.2. Market Analysis
   1.3. PMR Analysis and Recommendations
   1.4. Wheel of Fortune

2. Market Introduction
   2.1. Market Definition
   2.2. Market Taxonomy

3. Herpes Marker Testing Market View Point
   3.1. Macro-Economic Factors
   3.2. Opportunity Analysis
   3.3. Pricing Analysis
   3.4. Regulatory Scenario

4. North America Herpes Marker Testing Market Analysis 2012–2016 and Forecast 2017–2025
   4.1. Introduction
   4.2. Regional Market Dynamics
        4.2.1. Drivers
        4.2.2. Restraints
        4.2.3. Trends
   4.3. Historical Market Size (US$ Mn) By Country, 2012-2016
        4.3.1. U.S.
        4.3.2. Canada
   4.4. Market Size (US$ Mn) Forecast By Country, 2017-2025
        4.4.1. U.S.
        4.4.2. Canada
   4.5. Historical Market Size (US$ Mn) and volume By Test Type, 2012-2016
        4.5.1. Viral Culture Test
        4.5.2. Nucleic Acid Amplification-based Kits
        4.5.3. Antibody/Antigen-based Kits  
   4.6. Market Size (US$ Mn) and volume Forecast By Test Type, 2017-2025
        4.6.1. Viral Culture Test
        4.6.2. Nucleic Acid Amplification-based Kits
        4.6.3. Antibody/Antigen-based Kits  
   4.7. Historical Market Size (US$ Mn) By Indication, 2012-2016
        4.7.1. HSV-1
        4.7.2. HSV-2
        4.7.3. HSV-1/HSV-2
   4.8. Market Size (US$ Mn) Forecast By Indication, 2017-2025
        4.8.1. HSV-1
        4.8.2. HSV-2
        4.8.3. HSV-1/HSV-2
   4.9. Historical Market Size (US$ Mn) and volume By Application, 2012-2016
        4.9.1. Research-Use
        4.9.2. Clinical Diagnostics
   4.10. Market Size (US$ Mn) and volume Forecast By Application, 2017-2025
        4.10.1. Research-Use
        4.10.2. Clinical Diagnostics
   4.11. Historical Market Size (US$ Mn) By End Users, 2012-2016
        4.11.1. Hospitals
        4.11.2. Diagnostic Centers
        4.11.3. Clinics
        4.11.4. Academic & Research Institutes  
   4.12. Market Size (US$ Mn) Forecast By End Users, 2017-2025
        4.12.1. Hospitals
        4.12.2. Diagnostic Centers
        4.12.3. Clinics
        4.12.4. Academic & Research Institutes    
   4.13. Market Attractiveness Analysis
        4.13.1. By Country
        4.13.2. By Test Type
        4.13.3. By Indication
        4.13.4. By Application
        4.13.5. By End Users

5. Latin America Herpes Marker Testing Market Analysis 2012–2016 and Forecast 2017–2025
   5.1. Introduction
   5.2. Regional Market Dynamics
        5.2.1. Drivers
        5.2.2. Restraints
        5.2.3. Trends
   5.3. Historical Market Size (US$ Mn) By Country, 2012-2016
        5.3.1. Brazil
        5.3.2. Mexico
        5.3.3. Rest of Latin America
   5.4. Market Size (US$ Mn) Forecast By Country, 2017-2025
        5.4.1. Brazil
        5.4.2. Mexico
        5.4.3. Rest of Latin America
   5.5. Historical Market Size (US$ Mn) and volume By Test Type, 2012-2016
        5.5.1. Viral Culture Test
        5.5.2. Nucleic Acid Amplification-based Kits
        5.5.3. Antibody/Antigen-based Kits  
   5.6. Market Size (US$ Mn) and volume Forecast By Test Type, 2017-2025
        5.6.1. Viral Culture Test
        5.6.2. Nucleic Acid Amplification-based Kits
        5.6.3. Antibody/Antigen-based Kits  
   5.7. Historical Market Size (US$ Mn) By Indication, 2012-2016
        5.7.1. HSV-1
        5.7.2. HSV-2
        5.7.3. HSV-1/HSV-2
   5.8. Market Size (US$ Mn) Forecast By Indication, 2017-2025
        5.8.1. HSV-1
        5.8.2. HSV-2
        5.8.3. HSV-1/HSV-2
   5.9. Historical Market Size (US$ Mn) and volume By Application, 2012-2016
        5.9.1. Research-Use
        5.9.2. Clinical Diagnostics
   5.10. Market Size (US$ Mn) and volume Forecast By Application, 2017-2025
        5.10.1. Research-Use
        5.10.2. Clinical Diagnostics
   5.11. Historical Market Size (US$ Mn) By End Users, 2012-2016
        5.11.1. Hospitals
        5.11.2. Diagnostic Centers
        5.11.3. Clinics
        5.11.4. Academic & Research Institutes  
   5.12. Market Size (US$ Mn) Forecast By End Users, 2017-2025
        5.12.1. Hospitals
        5.12.2. Diagnostic Centers
        5.12.3. Clinics
        5.12.4. Academic & Research Institutes    
   5.13. Market Attractiveness Analysis
        5.13.1. By Country
        5.13.2. By Test Type
        5.13.3. By Indication
        5.13.4. By Application
        5.13.5. By End User

6. Europe Herpes Marker Testing Market Analysis 2012–2016 and Forecast 2017–2025
   6.1. Introduction
   6.2. Regional Market Dynamics
        6.2.1. Drivers
        6.2.2. Restraints
        6.2.3. Trends
   6.3. Historical Market Size (US$ Mn) By Country, 2012-2016
        6.3.1. Germany
        6.3.2. U.K.
        6.3.3. France
        6.3.4. Italy
        6.3.5. Spain
        6.3.6. Poland
        6.3.7. Russia
        6.3.8. Rest of Europe
   6.4. Market Size (US$ Mn) Forecast By Country, 2017-2025
        6.4.1. Germany
        6.4.2. U.K.
        6.4.3. France
        6.4.4. Italy
        6.4.5. Spain
        6.4.6. Russia
        6.4.7. Rest of Europe
   6.5. Historical Market Size (US$ Mn) and volume By Test Type, 2012-2016
        6.5.1. Viral Culture Test
        6.5.2. Nucleic Acid Amplification-based Kits
        6.5.3. Antibody/Antigen-based Kits  
   6.6. Market Size (US$ Mn) and volume Forecast By Test Type, 2017-2025
        6.6.1. Viral Culture Test
        6.6.2. Nucleic Acid Amplification-based Kits
        6.6.3. Antibody/Antigen-based Kits  
   6.7. Historical Market Size (US$ Mn) By Indication, 2012-2016
        6.7.1. HSV-1
        6.7.2. HSV-2
        6.7.3. HSV-1/HSV-2
   6.8. Market Size (US$ Mn) Forecast By Indication, 2017-2025
        6.8.1. HSV-1
        6.8.2. HSV-2
        6.8.3. HSV-1/HSV-2
   6.9. Historical Market Size (US$ Mn) and volume By Application, 2012-2016
        6.9.1. Research-Use
        6.9.2. Clinical Diagnostics
   6.10. Market Size (US$ Mn) and volume Forecast By Application, 2017-2025
        6.10.1. Research-Use
        6.10.2. Clinical Diagnostics
   6.11. Historical Market Size (US$ Mn) By End Users, 2012-2016
        6.11.1. Hospitals
        6.11.2. Diagnostic Centers
        6.11.3. Clinics
        6.11.4. Academic & Research Institutes  
   6.12. Market Size (US$ Mn) Forecast By End Users, 2017-2025
        6.12.1. Hospitals
        6.12.2. Diagnostic Centers
        6.12.3. Clinics
        6.12.4. Academic & Research Institutes    
   6.13. Market Attractiveness Analysis
        6.13.1. By Country
        6.13.2. By Test Type
        6.13.3. By Indication
        6.13.4. By Application
        6.13.5. By End Users

7. Asia Pacific (APAC) Herpes Marker Testing Market Analysis 2012–2016 and Forecast 2017–2025
   7.1. Introduction
   7.2. Regional Market Dynamics
        7.2.1. Drivers
        7.2.2. Restraints
        7.2.3. Trends
   7.3. Historical Market Size (US$ Mn) By Country, 2012-2016
        7.3.1. China
        7.3.2. India
        7.3.3. Japan
        7.3.4. Australia and New Zealand
        7.3.5. Rest of APAC
   7.4. Market Size (US$ Mn) Forecast By Country, 2017-2025
        7.4.1. China
        7.4.2. India
        7.4.3. Japan
        7.4.4. Australia and New Zealand
        7.4.5. Rest of APAC
   7.5. Historical Market Size (US$ Mn) and volume By Test Type, 2012-2016
        7.5.1. Viral Culture Test
        7.5.2. Nucleic Acid Amplification-based Kits
        7.5.3. Antibody/Antigen-based Kits  
   7.6. Market Size (US$ Mn) and volume Forecast By Test Type, 2017-2025
        7.6.1. Viral Culture Test
        7.6.2. Nucleic Acid Amplification-based Kits
        7.6.3. Antibody/Antigen-based Kits  
   7.7. Historical Market Size (US$ Mn) By Indication, 2012-2016
        7.7.1. HSV-1
        7.7.2. HSV-2
        7.7.3. HSV-1/HSV-2
   7.8. Market Size (US$ Mn) Forecast By Indication, 2017-2025
        7.8.1. HSV-1
        7.8.2. HSV-2
        7.8.3. HSV-1/HSV-2
   7.9. Historical Market Size (US$ Mn) and volume By Application, 2012-2016
        7.9.1. Research-Use
        7.9.2. Clinical Diagnostics
   7.10. Market Size (US$ Mn) and volume Forecast By Application, 2017-2025
        7.10.1. Research-Use
        7.10.2. Clinical Diagnostics
   7.11. Historical Market Size (US$ Mn) By End Users, 2012-2016
        7.11.1. Hospitals
        7.11.2. Diagnostic Centers
        7.11.3. Clinics
        7.11.4. Academic & Research Institutes  
   7.12. Market Size (US$ Mn) Forecast By End Users, 2017-2025
        7.12.1. Hospitals
        7.12.2. Diagnostic Centers
        7.12.3. Clinics
        7.12.4. Academic & Research Institutes    
   7.13. Market Attractiveness Analysis
        7.13.1. By Country
        7.13.2. By Test Type
        7.13.3. By Indication
        7.13.4. By Application
        7.13.5. By End Users

8. Middle East and Africa (MEA) Herpes Marker Testing Market Analysis 2012–2016 and Forecast 2017–2025
   8.1. Introduction
   8.2. Regional Market Dynamics
        8.2.1. Drivers
        8.2.2. Restraints
        8.2.3. Trends
   8.3. Historical Market Size (US$ Mn) By Country, 2012-2016
        8.3.1. GCC Countries
        8.3.2. South Africa
        8.3.3. Rest of MEA
   8.4. Market Size (US$ Mn) Forecast By Country, 2017-2025
        8.4.1. GCC Countries
        8.4.2. South Africa
        8.4.3. Rest of MEA
   8.5. Historical Market Size (US$ Mn) and volume By Test Type, 2012-2016
        8.5.1. Viral Culture Test
        8.5.2. Nucleic Acid Amplification-based Kits
        8.5.3. Antibody/Antigen-based Kits  
   8.6. Market Size (US$ Mn) and volume Forecast By Test Type, 2017-2025
        8.6.1. Viral Culture Test
        8.6.2. Nucleic Acid Amplification-based Kits
        8.6.3. Antibody/Antigen-based Kits  
   8.7. Historical Market Size (US$ Mn) By Indication, 2012-2016
        8.7.1. HSV-1
        8.7.2. HSV-2
        8.7.3. HSV-1/HSV-2
   8.8. Market Size (US$ Mn) Forecast By Indication, 2017-2025
        8.8.1. HSV-1
        8.8.2. HSV-2
        8.8.3. HSV-1/HSV-2
   8.9. Historical Market Size (US$ Mn) and volume By Application, 2012-2016
        8.9.1. Research-Use
        8.9.2. Clinical Diagnostics
   8.10. Market Size (US$ Mn) and volume Forecast By Application, 2017-2025
        8.10.1. Research-Use
        8.10.2. Clinical Diagnostics
   8.11. Historical Market Size (US$ Mn) By End Users, 2012-2016
        8.11.1. Hospitals
        8.11.2. Diagnostic Centers
        8.11.3. Clinics
        8.11.4. Academic & Research Institutes  
   8.12. Market Size (US$ Mn) Forecast By End Users, 2017-2025
        8.12.1. Hospitals
        8.12.2. Diagnostic Centers
        8.12.3. Clinics
        8.12.4. Academic & Research Institutes    
   8.13. Market Attractiveness Analysis
        8.13.1. By Country
        8.13.2. By Test Type
        8.13.3. By Indication
        8.13.4. By Application
        8.13.5. By End Users

9. Competition Landscape
   9.1. Market Structure
   9.2. Market Share Analysis
   9.3. Competition Dashboard
   9.4. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
   9.5. Key Players
        9.5.1. Abbott Laboratories
        9.5.2. Abcam Plc
        9.5.3. BioMérieux SA
        9.5.4. Thermo Fisher Scientific, Inc.
        9.5.5. F. Hoffmann-La Roche Ltd.
        9.5.6. DiaSorin S.p.A.
        9.5.7. Quidel Corporation
        9.5.8. Luminex Corporation
        9.5.9. Merck KGaA
        9.5.10. Qiagen N.V.
        9.5.11. Norgen Biotek Corp.
        9.5.12. Hologic Inc.
        9.5.13. Bio Rad Laboratories Inc.
        9.5.14. Meridian Bioscience Inc.
        9.5.15. Teco Diagnostics

10. Global Herpes Marker Testing Market Analysis 2012–2016 and Forecast 2017–2025, By Region
   10.1. Introduction
        10.1.1. Basis Point Share (BPS) Analysis By Region
        10.1.2. Y-o-Y Growth Projections By Region
   10.2. Historical Market Size Analysis 2012–2016, By Region
        10.2.1. North America
        10.2.2. Latin America
        10.2.3. Europe
        10.2.4. Asia Pacific (APAC)
        10.2.5. Middle East and Africa (MEA)
   10.3. Market Size Analysis 2017–2015, By Region
        10.3.1. North America
        10.3.2. Latin America
        10.3.3. Europe
        10.3.4. Asia Pacific (APAC)
        10.3.5. Middle East and Africa (MEA)
   10.4. Market Attractiveness Analysis By Region

11. Global Herpes Marker Testing Market Analysis 2012–2016 and Forecast 2017–2025, By Test Type
   11.1. Introduction
        11.1.1. Basis Point Share (BPS) Analysis By Test Type
        11.1.2. Y-o-Y Growth Projections By Test Type
   11.2. Historical Market Size (US$ Mn) and volume By Test Type, 2012-2016
        11.2.1. Viral Culture Test
        11.2.2. Nucleic Acid Amplification-based Kits
        11.2.3. Antibody/Antigen-based Kits
   11.3. Market Size (US$ Mn) and volume Forecast By Test Type, 2017-2025
        11.3.1. Viral Culture Test
        11.3.2. Nucleic Acid Amplification-based Kits
        11.3.3. Antibody/Antigen-based Kits
   11.4. Market Attractiveness Analysis By Test Type

12. Global Herpes Marker Testing Market Analysis 2012–2016 and Forecast 2017–2025, By Indication
   12.1. Introduction
        12.1.1. Basis Point Share (BPS) Analysis By Indication
        12.1.2. Y-o-Y Growth Projections By Indication
   12.2. Historical Market Size (US$ Mn) By Indication, 2012-2016
        12.2.1. HSV-1
        12.2.2. HSV-2
        12.2.3. HSV-1/HSV-2
   12.3. Market Size (US$ Mn) Forecast By Indication, 2017-2025
        12.3.1. HSV-1
        12.3.2. HSV-2
        12.3.3. HSV-1/HSV-2
   12.4. Market Attractiveness Analysis By Indication

13. Global Herpes Marker Testing Market Analysis 2012–2016 and Forecast 2017–2025, By Application
   13.1. Introduction
        13.1.1. Basis Point Share (BPS) Analysis By Application
        13.1.2. Y-o-Y Growth Projections By Application
   13.2. Historical Market Size (US$ Mn) By Application, 2012-2016
        13.2.1. Research-Use
        13.2.2. Clinical Diagnostics
   13.3. Market Size (US$ Mn) Forecast By Application, 2017-2025
        13.3.1. Research-Use
        13.3.2. Clinical Diagnostics
   13.4. Market Attractiveness Analysis By Application

14. Global Herpes Marker Testing Market Analysis 2012–2016 and Forecast 2017–2025, By End Users
   14.1. Introduction
        14.1.1. Basis Point Share (BPS) Analysis By End Users
        14.1.2. Y-o-Y Growth Projections By End Users
   14.2. Historical Market Size (US$ Mn) By End Users, 2012-2016
        14.2.1. Hospitals
        14.2.2. Diagnostic Centers
        14.2.3. Clinics
        14.2.4. Academic & Research Institutes
   14.3. Market Size (US$ Mn) Forecast By End Users, 2017-2025
        14.3.1. Hospitals
        14.3.2. Diagnostic Centers
        14.3.3. Clinics
        14.3.4. Academic & Research Institutes
   14.4. Market Attractiveness Analysis By End Users

15. Global Herpes Marker Testing Market Analysis 2012–2016 and Forecast 2017–2025
   15.1. Market Size and Y-o-Y Growth
   15.2. Absolute $ Opportunity

16. Assumptions and Acronyms Used

Custom Market Research Services

MRRSE offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Get A Free Custom Research Quote